MyBlueDotsOdyssey Therapeutics Appoints Jason Haas as Chief Financial Officer MyBlueDots4 weeks ago01 mins BOSTON–(BUSINESS WIRE)–Odyssey Therapeutics, Inc. today announced the appointment of Jason Haas, MBA, as chief financial officer (CFO). Post navigation Previous: GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 PatientsNext: Pet Honesty® Named Official Multivitamin Supplement of the American Kennel Club
GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds MyBlueDots5 hours ago 0
Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics MyBlueDots5 hours ago 0